TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.

Laura M Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.